LYSELÖSUNG ROTER BLUTKÖRPERCHEN

European patent · EP3209799 · In force

Register entry

Publication number
EP3209799
Application number
EP15851970
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 20, 2015
Published
Aug 30, 2017
Granted
Jul 8, 2020
Protection ends at the latest
Oct 19, 2035
Next annual fee due
Oct 31, 2026
IPC classes
C12Q 1/6806 (2018.01)
Priority
US 201462066244 P 20.10.2014
PCT application
PCT/US2015/056480 20.10.2015
PCT publication
WO2016/064887 28.04.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. May 9, 2023

    Address changed

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 09.05.2023

  5. Nov 17, 2022

    Change

    Published in Swissreg on 17.11.2022

  6. Jul 28, 2020

    Agent entered

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 28.07.2020

  7. Jul 8, 2020

    Granted

    Published in Swissreg on 08.07.2020

Parties

Holder

Gen-Probe Incorporated

10210 Genetic Center Drive, San Diego, CA 92121, US

Agent

VALIPAT

c/o BOVARD LTD Optingenstrasse 16, 3013 Bern

Inventor

LINNEN, Jeffrey M.

Poway, California 92064, US

CHELLISERRY, Jijumon

San Diego, California 92129, US

GAO, Kui

San Diego, California 92131, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.